Cangrelor Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention. Results of the CHAMPION PCI Study

被引:0
|
作者
Preobrazhensky, D., V
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:63 / 64
页数:2
相关论文
共 50 条
  • [2] Pharmacodynamic Effects of Cangrelor and Clopidogrel: The Platelet Function Substudy from the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition in Patients Undergoing Percutaneous Coronary Intervention (CHAMPION-PCI) Trial
    Angiolillo, Dominick J.
    Schneider, David J.
    Bhatt, Deepak L.
    French, William J.
    Price, Matthew J.
    Saucedo, Jorge F.
    Shaburishvili, Tamaz
    Huber, Kurt
    Prats, Jayne
    Liu, Tiepu
    Harrington, Robert A.
    Becker, Richard
    CIRCULATION, 2011, 124 (21)
  • [3] Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention Findings From CHAMPION PHOENIX
    Cavender, Matthew A.
    Bhatt, Deepak L.
    Stone, Gregg W.
    Steg, Ph. Gabriel
    Gibson, C. Michael
    Hamm, Christian W.
    Price, Matthew J.
    Prats, Jayne
    Elkin, Steven
    Deliargyris, Efthymios N.
    Mahaffey, Kenneth W.
    White, Harvey D.
    Harrington, Robert A.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (08)
  • [4] Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin Insights From the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI])
    White, Harvey D.
    Bhatt, Deepak L.
    Gibson, C. Michael
    Hamm, Christian W.
    Mahaffey, Kenneth W.
    Price, Matthew J.
    Steg, Ph. Gabriel
    Stone, Gregg W.
    Cortese, Bernardo
    Wilensky, Michael
    Deliargyris, Efthymios N.
    Liu, Tiepu
    Prats, Jayne
    Harrington, Robert A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (03) : 424 - 433
  • [5] Cangrelor: a new CHAMPION for percutaneous coronary intervention
    Mehta, Shamir R.
    LANCET, 2013, 382 (9909): : 1960 - 1962
  • [6] Effects of eptifibatide, bivalirudin and clopidogrel on platelet function in patients undergoing percutaneous coronary intervention. Final results of the DEACON study
    Saucedo, JF
    Thorn, B
    Aude, W
    Pacheco, R
    Shuler, S
    Matin, Z
    Gudapati, S
    Garza, L
    CIRCULATION, 2003, 108 (17) : 576 - 576
  • [7] CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Zeb, Shah
    Shah, Ibrahim
    Adil, Mohammad
    Ali, Jabar
    Jan, Hikmatullah
    Gul, Adnan Mahmood
    Hafizullah, Mohammad
    PAKISTAN HEART JOURNAL, 2016, 49 (03): : 107 - 112
  • [8] DIRECT MEDICAL COST COMPARISON BETWEEN PATIENTS RECEIVING CANGRELOR AND CLOPIDOGREL DURING PERCUTANEOUS CORONARY INTERVENTION: CHAMPION PHOENIX ECONOMIC SUB-STUDY RESULTS
    Nicholson, G.
    Cyr, P.
    Fan, W.
    Plent, S.
    VALUE IN HEALTH, 2015, 18 (03) : A148 - A148
  • [9] Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
    Dominick J. Angiolillo
    Deepak L. Bhatt
    Ph. Gabriel Steg
    Gregg W. Stone
    Harvey D. White
    C. Michael Gibson
    Christian W. Hamm
    Matthew J. Price
    Jayne Prats
    Tiepu Liu
    Kenneth W. Mahaffey
    Robert A. Harrington
    Journal of Thrombosis and Thrombolysis, 2015, 40 : 317 - 322
  • [10] IMPACT OF CANGRELOR OVERDOSING ON BLEEDING COMPLICATIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CHAMPION TRIALS
    Angiolillo, Dominick J.
    Bhatt, Deepak
    Steg, Philippe
    Stone, Gregg
    White, Harvey
    Gibson, C. Michael
    Hamm, Christian
    Price, Matthew
    Prats, Jayne
    Liu, Tiepu
    Day, Jonathan
    Mahaffey, Kenneth
    Harrington, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1905 - A1905